ERBB2 and cancer: Importantly, HER2/neu overexpression has been previously reported to be associated with cancer cell proliferation, poor survival, and resistance to therapy in multiple human tumours (Slamon et al, 1987; Berchuck et al, 1990, 1991; Hetzel et al, 1992; Santin et al, 2005).